Whether it concerns the design of a new method or the improvement of an existing one to bring it in line with the latest technology, method development has many facets. Often, regulatory updates or changes will necessitate the development of methods.
On behalf of our clients, we develop concept-based scientifically sound and cost-effective analysis methods. We also draft development plans and reports, testing instructions, and validation plans and reports.
We support the transfer of methods to clients or third parties through coordinated method transfers. Diapharm Analytics also provides coordinated project management, drawing on external qualified partners as required.
To gain marketing authorisation or registration of a medicinal product, the validity of test methods has to be demonstrated. Diapharm Analytics assists clients in creating appropriate validation plans and validating methods in accordance with ICH guideline Q2(R1). If the need arises, we manage the transfer of methods to routine laboratory analysis, including the drafting of transfer plans and reports.
As a matter of course, we also offer adequately customised validations for related product categories, such as food supplements, cosmetics or medical devices.
Using validated and robust methods brings reliability to your routine processes. At the same time, it gives you the necessary scope to manoeuvre, when flexibility is required.